Prof Rozita Rosli currently heads the UPM-MAKNA Cancer Research Laboratory at the Institute of Bioscience, UPM where she initiated the translational genomics research program which focuses on application of new molecular technologies in the identification of genetic and epigenetic alterations of various pathways of carcinogenesis or the cancer microenvironment of common cancers, especially that of the Asian-specific genetic variation. She previously served as Deputy Dean for Research and Graduate Studies (2004 – 2010) at the Faculty of Medicine and Health Sciences, UPM. She received her tertiary education in the United States, obtaining her undergraduate degree in Biology from Purdue University, her Masters and doctoral degree in 1986 and 1994 respectively from Ball State University where her laboratory skills in molecular biology was honed. She subsequently pursued her post-doctoral training at the Indiana University School of Medicine in the area of Hematology/Oncology where her interest in cancer research developed. Her current research interest mainly lies in the application of genomics and proteomics as tools in understanding and combating genetic diseases, especially cancer as well as infectious diseases. Together with her graduate students, her work has led to the publication of more than a hundred research articles, the development of DNA vaccines, molecular diagnostic tools, the production of therapeutics from natural products and a number of related patents.